Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blinded, Placebo-controlled Study to Assess the Safety and Bioactivity of Sodium Polysulthionate (SG1002) in Heart Failure Patients

NCT02278276 is registered in ClinicalTrials.gov with Sulfagenix Australia Pty Ltd. as lead sponsor.

NCT NCT02278276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02278276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blinded, Placebo-controlled Study to Assess the Safety and Bioactivity of Sodium Polysulthionate (SG1002) in Heart Failure Patients
Lead sponsor
Sulfagenix Australia Pty Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2016
Completion date
July 31, 2018
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure